{"id":11510,"date":"2022-07-01T20:41:24","date_gmt":"2022-07-01T20:41:24","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021\/"},"modified":"2022-07-01T20:41:24","modified_gmt":"2022-07-01T20:41:24","slug":"inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021","title":{"rendered":"Inmunoterapia contra el c\u00e1ncer: Estudios y perspectivas en 2021"},"content":{"rendered":"<p><iframe loading=\"lazy\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/kaOdTf5BGPs\" width=\"560\"><\/iframe><\/p>\n<p>El a\u00f1o pasado se produjeron avances en inmunoterapia para varios tipos de c\u00e1ncer, ampliando sus beneficios a m\u00e1s pacientes, tanto j\u00f3venes como mayores. Los avances en tratamientos y an\u00e1lisis de biomarcadores permiten a los m\u00e9dicos personalizar m\u00e1s que nunca el abordaje para cada paciente, a pesar de que todav\u00eda queda mucho por hacer.<\/p>\n<p>En este seminario web para pacientes y cuidadores, el <a href=\"https:\/\/www.cancerresearch.org\/scientific-advisory-council\/kunle-odunsi\"><strong>Dr. Kunle Odunsi, MD,&nbsp;Ph.D.<!-- strong --><\/strong><\/a>, del Centro Oncol\u00f3gico Roswell Park, analiza estos importantes hitos, lo que podr\u00eda surgir en este campo en 2021 y su impacto en los pacientes. El Dr. Odunsi abordar\u00e1 diversos temas relacionados con la inmunoterapia, a saber:<\/p>\n<ul>\n<li>nuevas aplicaciones de inmunoterapias con inhibidores de puntos de control<\/li>\n<li>combinaciones de inmunoterapias con otros tratamientos<\/li>\n<li>uso de biomarcadores para el emparejamiento de pacientes con inmunoterapias<\/li>\n<li>estrategias prometedoras de terapia celular, y m\u00e1s.<\/li>\n<\/ul>\n<p><img decoding=\"async\" alt=\"Kunle Odunsi\" src=\"\/getmedia\/a17d483b-0959-4621-80ef-4c63af1f2be1\/kunle-odunsi.jpg.aspx;.xml?width=199&amp;height=229\" style=\"width: 199px; height: 229px; float: left; margin: 10px;\" \/>El Dr. Kunle Odunsi es director adjunto del Centro Oncol\u00f3gico Roswell Park, adem\u00e1s de titular de la c\u00e1tedra subvencionada Robert, Anne y Lew Wallace de inmunoterapia contra el c\u00e1ncer y director ejecutivo de su Centro de inmunoterapia. Asimismo, es presidente y profesor M. Steven Piver del Departamento de Oncolog\u00eda Ginecol\u00f3gica de Roswell Park, director adjunto del Consejo Asesor Cient\u00edfico del CRI y, en 2018, ingres\u00f3 a la Academia Nacional de Medicina.<\/p>\n<p>La serie de seminarios web &laquo;La inmunoterapia y usted&raquo; es una producci\u00f3n del CRI presentada por nuestro redactor cient\u00edfico senior, <a href=\"https:\/\/www.cancerresearch.org\/our-team\/arthur-n-brodsky-phd\">Arthur N. Brodsky, Ph. D.<\/a> La serie 2021 es posible gracias al generoso apoyo de Bristol Myers Squibb y Alkermes.<\/p>\n<p>Consulte nuestra lista de reproducci\u00f3n de la serie de seminarios web&nbsp;<a href=\"https:\/\/www.youtube.com\/playlist?list=PLiGDIj2dVt-iOiV34MnZIkTiVF3iFgF_o\" target=\"_blank\" rel=\"noopener\">La inmunoterapia y usted en YouTube<\/a> o visite la p\u00e1gina de <a href=\"\/events\/webinars\">seminarios web en nuestro sitio web<\/a> para ver otros seminarios de esta serie.<\/p>\n<p style=\"text-align: center;\"><strong><img decoding=\"async\" alt=\"Bristol Myers Squibb\" src=\"\/CRI\/media\/partners\/bms_logo_rgb_pos_300x42.png\" \/><\/strong><\/p>\n<p style=\"text-align: center;\"><strong><img decoding=\"async\" alt=\"Alkermes\" src=\"\/getmedia\/580534fc-50a1-487b-9d87-1c1d33fd5095\/thumbnail_alkermes-logo-color-600w-x-200h.png.aspx;.xml?width=200&amp;height=66\" style=\"width: 200px; height: 66px;\" \/><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Dr. Kunle Odunsi de Roswell Park&nbsp;analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.<\/p>\n","protected":false},"featured_media":1571,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11510","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Inmunoterapia contra el c\u00e1ncer 2021<\/title>\n<meta name=\"description\" content=\"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inmunoterapia contra el c\u00e1ncer 2021\" \/>\n<meta property=\"og:description\" content=\"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/8a1224a6-fc97-4e3a-b5d6-f45bbcdd80fd.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Inmunoterapia contra el c\u00e1ncer 2021\" \/>\n<meta name=\"twitter:description\" content=\"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/8a1224a6-fc97-4e3a-b5d6-f45bbcdd80fd.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021\",\"name\":\"Inmunoterapia contra el c\u00e1ncer 2021\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/117d6719-695d-4a19-a16d-738d9502fd5b.jpg\",\"datePublished\":\"2022-07-01T20:41:24+00:00\",\"description\":\"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/117d6719-695d-4a19-a16d-738d9502fd5b.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/117d6719-695d-4a19-a16d-738d9502fd5b.jpg\",\"width\":700,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Inmunoterapia contra el c\u00e1ncer: Estudios y perspectivas en 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inmunoterapia contra el c\u00e1ncer 2021","description":"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021","og_locale":"es_ES","og_type":"article","og_title":"Inmunoterapia contra el c\u00e1ncer 2021","og_description":"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.","og_url":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021","og_site_name":"Cancer Research Institute","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/8a1224a6-fc97-4e3a-b5d6-f45bbcdd80fd.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Inmunoterapia contra el c\u00e1ncer 2021","twitter_description":"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/8a1224a6-fc97-4e3a-b5d6-f45bbcdd80fd.jpg","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021","url":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021","name":"Inmunoterapia contra el c\u00e1ncer 2021","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/117d6719-695d-4a19-a16d-738d9502fd5b.jpg","datePublished":"2022-07-01T20:41:24+00:00","description":"El Dr. Kunle Odunsi de Roswell Park\u00a0analiza lo que podr\u00eda surgir en la materia en 2021 y su impacto en los pacientes.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/117d6719-695d-4a19-a16d-738d9502fd5b.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/117d6719-695d-4a19-a16d-738d9502fd5b.jpg","width":700,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/inmunoterapia-contra-el-cancer-estudios-y-perspectivas-en-2021#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Inmunoterapia contra el c\u00e1ncer: Estudios y perspectivas en 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/1571"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11510"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11510"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11510"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11510"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11510"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11510"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}